ID
43819
Description
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01463072
Link
https://clinicaltrials.gov/show/NCT01463072
Keywords
Versions (2)
- 3/13/16 3/13/16 -
- 9/20/21 9/20/21 -
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Male Breast Cancer NCT01463072
Eligibility Male Breast Cancer NCT01463072
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Study Subject Participation Status
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
CNS metastases; dosage corticosteroids
Data type
boolean
Alias
- UMLS CUI [1]
- C0686377
- UMLS CUI [2,1]
- C0178602
- UMLS CUI [2,2]
- C0001617
Description
hypersensitivity paclitaxel
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0144576
Description
infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
adjuvant therapy taxane
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0677850
- UMLS CUI [1,2]
- C0215136
Similar models
Eligibility Male Breast Cancer NCT01463072
- StudyEvent: Eligibility
C0034833 (UMLS CUI [2])
C3496586 (UMLS CUI [3])
C0027627 (UMLS CUI [1,2])
C0002170 (UMLS CUI [1,2])
C0178602 (UMLS CUI [2,1])
C0001617 (UMLS CUI [2,2])
C0144576 (UMLS CUI [1,2])
C0215136 (UMLS CUI [1,2])